Laboratory Centrifuges Market

The laboratory centrifuges market is expected to reach USD 1.86 billion by 2030, up from USD 1.58 billion in 2025, growing at a CAGR of 2.8% from 2025 to 2030. Centrifuges are commonly used in laboratories for research in chemistry, biology, and biochemistry. They are essential for research involving the separation of various components. These devices are utilized across a range of settings, from academic to clinical research, for the separation and purification of cells, subcellular organelles, viruses, proteins, and nucleic acids.

Factors such as increasing R&D investments and research grants; rising technological advancements and innovative rotor designs; the growing prevalence of infectious diseases leading to a higher volume of sample testing and cell-based research in laboratory centrifuges; and expanding applications of laboratory centrifuges are driving this market’s growth. The Asia Pacific market is projected to be the fastest-growing regional market, mainly due to the presence of emerging economies like China and India and the increasing R&D investments by pharmaceutical and biotechnology companies in this region.

The laboratory centrifuges market is highly competitive, with a few well-established players dominating the overall market. The key companies operating in this market include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), KUBOTA Corporation (Japan), Sigma Laborzentrifugen GmbH (Germany), NuAire (US), Sartorius AG (Germany), Andreas Hettich GmbH & Co. KG (Germany), HERMLE Labortechnik GmbH (Germany), Cardinal Health (US), Agilent Technologies (US), Centurion Scientific (UK), QIAGEN N.V. (Netherlands), and Bio-Rad Laboratories, Inc. (US).

To know about the assumptions considered for the study download the pdf brochure

Market leaders succeed by leveraging well-established brand credibility, wide-ranging product portfolios, advanced technological skills, and extensive service networks. Their strategic ecosystem partnerships and deep regulatory expertise further strengthen their competitive edge, allowing them to promote adoption effectively in both developed and emerging markets.

Thermo Fisher Scientific Inc. (US)

Thermo Fisher Scientific, Inc. (US) is recognized as a leading player in the global laboratory centrifuges market. The company’s strong brand recognition and extensive product portfolio in this market are its key strengths. To maintain its market leadership, the company focuses on R&D activities to develop and introduce new products. Over the past three years, the company has increased its R&D expenditure. Thermo Fisher Scientific also has a robust promotional strategy and participates in various trade shows, seminars, and workshops to promote its products. The company operates in more than 600 locations across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Danaher (US)

Danaher Corporation (US) is a key player in the global laboratory centrifuges market. The acquisition of Beckman Coulter by Danaher, a major competitor in this market, was part of a strategy to expand their offerings. This acquisition allowed Danaher to broaden its product portfolio in clinical diagnostics by adding new and complementary products. The company also emphasizes product development, which led to the launch of the Avanti JXN-30 centrifuge. Over the past few years, Danaher has strengthened its business over four decades by acquiring and integrating new companies into a unified entity and improving them through the Danaher Business System (DBS), a set of distinctive management practices.

The company operates in North America, Europe, and Asia Pacific, with 242 manufacturing and distribution facilities worldwide.

Eppendorf AG (Germany)

Eppendorf AG (Germany) is recognized as a top player in the global laboratory centrifuges market. Its leading market position is mainly due to its focus on product innovation. The company emphasizes developing its R&D capabilities, core competencies, and meeting customer and market needs. This approach has enabled Eppendorf to launch innovative products. It introduced its Multipurpose Centrifuge 5910 Ri, Refrigerated 24-place centrifuge 5425 R, and Refrigerated 24-place centrifuge 5425. These launches strengthened the company’s product range, brand recognition, and helped it maintain its market position. Eppendorf has a strong presence across Europe, North America, South America, Asia Pacific, and Africa. It also operates subsidiaries in more than 28 countries.

With the acquisition of a Japan-based centrifuge manufacturer, Koki Holdings Co., Ltd. (Japan), Eppendorf now offers a range of durable high-speed, ultra-speed, and other centrifuges.

Market Ranking

The lab centrifuge market is fairly consolidated, with five to six main players holding about 50-60% of the global market share. Thermo Fisher Scientific, Inc. (US) is the industry leader, thanks to its strong brand portfolio, extensive global distribution, and significant R&D investment. Following closely are Danaher Corporation (US) and Eppendorf AG (Germany). Each of these key companies contributes to the market through partnerships, interoperability, and workflow integration.

Related Reports:

Laboratory Centrifuges Market by Product [Equipment (Microcentrifuge, Ultracentrifuge), Accessories (Tube, Plate)], Platform (Benchtop), Rotor Design (Swinging-bucket), Intended Use (Clinical), Application (Diagnostics), End User (Hospitals) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com